Nucleoside phosphorylases

Nucleoside phosphorylases (NPs) are transferases that catalyse the reversible cleavage of the glycosidic bond of ribo- or deoxyribo nucleosides, in the presence of inorganic phosphate, to generate the base and ribose- or deoxyribose-1-phosphate. Since pyrimidine as well as purine nucleoside phosphor...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado: 2006
Materias:
Acceso en línea:https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_13852728_v10_n11_p1197_Lewkowicz
http://hdl.handle.net/20.500.12110/paper_13852728_v10_n11_p1197_Lewkowicz
Aporte de:
id paper:paper_13852728_v10_n11_p1197_Lewkowicz
record_format dspace
spelling paper:paper_13852728_v10_n11_p1197_Lewkowicz2023-06-08T16:12:42Z Nucleoside phosphorylases Azanucleosides Coupled enzymatic systems Glycosyltransfer reaction Immobilisation NP-I family TP-catalysed phosphorolysis 2 deoxyribose 2,6 diaminopurine 2',3' dideoxyriboside abacavir adenosine deaminase amdoxovir antiinfective agent antineoplastic agent azathioprine benzimidazole derivative cladribine cytarabine didanosine dihydropyrimidine dehydrogenase fludarabine gemcitabine glycoside lamivudine nicotinamide riboside nucleoside derivative nucleoside phosphorylase phosphate ribamidine ribavirin RNA directed DNA polymerase inhibitor stavudine tubercidin unindexed drug xanthine oxidase zalcitabine zidovudine antineoplastic activity antiviral activity binding affinity catalysis DNA synthesis drug screening drug structure drug synthesis drug targeting enzyme activity enzyme binding enzyme mechanism gene therapy glycosylation human nonhuman nucleotide metabolism review RNA synthesis structure activity relation structure analysis Nucleoside phosphorylases (NPs) are transferases that catalyse the reversible cleavage of the glycosidic bond of ribo- or deoxyribo nucleosides, in the presence of inorganic phosphate, to generate the base and ribose- or deoxyribose-1-phosphate. Since pyrimidine as well as purine nucleoside phosphorylases exist, the combination of both enzymes makes possible the generation of purine nucleosides from pyrimidine ones. As a consequence, NPs from different sources, mainly bacterial, have been exploited as tools for the enzymatic synthesis of nucleoside analogues. These molecules are extensively used as antiviral and anticancer agents because of their ability to act as reverse transcriptase inhibitors or chain terminators in RNA or DNA synthesis. This review covers literature reports from 2000 on, focused mainly on the synthesis of nucleosides by free and immobilised microbial whole cells, along with some examples of modified nucleosides obtained by coupling transglycosylation to other enzymatic reactions. The biological aspects of NPs are also discussed since they became an interesting target for clinical applications due to their key role in nucleotide metabolism. Finally, brief comments about their structures and catalytic mechanisms are included. © 2006 Bentham Science Publishers Ltd. 2006 https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_13852728_v10_n11_p1197_Lewkowicz http://hdl.handle.net/20.500.12110/paper_13852728_v10_n11_p1197_Lewkowicz
institution Universidad de Buenos Aires
institution_str I-28
repository_str R-134
collection Biblioteca Digital - Facultad de Ciencias Exactas y Naturales (UBA)
topic Azanucleosides
Coupled enzymatic systems
Glycosyltransfer reaction
Immobilisation
NP-I family
TP-catalysed phosphorolysis
2 deoxyribose
2,6 diaminopurine 2',3' dideoxyriboside
abacavir
adenosine deaminase
amdoxovir
antiinfective agent
antineoplastic agent
azathioprine
benzimidazole derivative
cladribine
cytarabine
didanosine
dihydropyrimidine dehydrogenase
fludarabine
gemcitabine
glycoside
lamivudine
nicotinamide riboside
nucleoside derivative
nucleoside phosphorylase
phosphate
ribamidine
ribavirin
RNA directed DNA polymerase inhibitor
stavudine
tubercidin
unindexed drug
xanthine oxidase
zalcitabine
zidovudine
antineoplastic activity
antiviral activity
binding affinity
catalysis
DNA synthesis
drug screening
drug structure
drug synthesis
drug targeting
enzyme activity
enzyme binding
enzyme mechanism
gene therapy
glycosylation
human
nonhuman
nucleotide metabolism
review
RNA synthesis
structure activity relation
structure analysis
spellingShingle Azanucleosides
Coupled enzymatic systems
Glycosyltransfer reaction
Immobilisation
NP-I family
TP-catalysed phosphorolysis
2 deoxyribose
2,6 diaminopurine 2',3' dideoxyriboside
abacavir
adenosine deaminase
amdoxovir
antiinfective agent
antineoplastic agent
azathioprine
benzimidazole derivative
cladribine
cytarabine
didanosine
dihydropyrimidine dehydrogenase
fludarabine
gemcitabine
glycoside
lamivudine
nicotinamide riboside
nucleoside derivative
nucleoside phosphorylase
phosphate
ribamidine
ribavirin
RNA directed DNA polymerase inhibitor
stavudine
tubercidin
unindexed drug
xanthine oxidase
zalcitabine
zidovudine
antineoplastic activity
antiviral activity
binding affinity
catalysis
DNA synthesis
drug screening
drug structure
drug synthesis
drug targeting
enzyme activity
enzyme binding
enzyme mechanism
gene therapy
glycosylation
human
nonhuman
nucleotide metabolism
review
RNA synthesis
structure activity relation
structure analysis
Nucleoside phosphorylases
topic_facet Azanucleosides
Coupled enzymatic systems
Glycosyltransfer reaction
Immobilisation
NP-I family
TP-catalysed phosphorolysis
2 deoxyribose
2,6 diaminopurine 2',3' dideoxyriboside
abacavir
adenosine deaminase
amdoxovir
antiinfective agent
antineoplastic agent
azathioprine
benzimidazole derivative
cladribine
cytarabine
didanosine
dihydropyrimidine dehydrogenase
fludarabine
gemcitabine
glycoside
lamivudine
nicotinamide riboside
nucleoside derivative
nucleoside phosphorylase
phosphate
ribamidine
ribavirin
RNA directed DNA polymerase inhibitor
stavudine
tubercidin
unindexed drug
xanthine oxidase
zalcitabine
zidovudine
antineoplastic activity
antiviral activity
binding affinity
catalysis
DNA synthesis
drug screening
drug structure
drug synthesis
drug targeting
enzyme activity
enzyme binding
enzyme mechanism
gene therapy
glycosylation
human
nonhuman
nucleotide metabolism
review
RNA synthesis
structure activity relation
structure analysis
description Nucleoside phosphorylases (NPs) are transferases that catalyse the reversible cleavage of the glycosidic bond of ribo- or deoxyribo nucleosides, in the presence of inorganic phosphate, to generate the base and ribose- or deoxyribose-1-phosphate. Since pyrimidine as well as purine nucleoside phosphorylases exist, the combination of both enzymes makes possible the generation of purine nucleosides from pyrimidine ones. As a consequence, NPs from different sources, mainly bacterial, have been exploited as tools for the enzymatic synthesis of nucleoside analogues. These molecules are extensively used as antiviral and anticancer agents because of their ability to act as reverse transcriptase inhibitors or chain terminators in RNA or DNA synthesis. This review covers literature reports from 2000 on, focused mainly on the synthesis of nucleosides by free and immobilised microbial whole cells, along with some examples of modified nucleosides obtained by coupling transglycosylation to other enzymatic reactions. The biological aspects of NPs are also discussed since they became an interesting target for clinical applications due to their key role in nucleotide metabolism. Finally, brief comments about their structures and catalytic mechanisms are included. © 2006 Bentham Science Publishers Ltd.
title Nucleoside phosphorylases
title_short Nucleoside phosphorylases
title_full Nucleoside phosphorylases
title_fullStr Nucleoside phosphorylases
title_full_unstemmed Nucleoside phosphorylases
title_sort nucleoside phosphorylases
publishDate 2006
url https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_13852728_v10_n11_p1197_Lewkowicz
http://hdl.handle.net/20.500.12110/paper_13852728_v10_n11_p1197_Lewkowicz
_version_ 1768544698235879424